% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Werner:874716,
      author       = {Werner, J. M. and Lohmann, P. and Fink, G. R. and Langen,
                      K. J. and Galldiks, N.},
      title        = {{C}urrent landscape and emerging fields of {PET} imaging in
                      patients with brain tumors},
      journal      = {Molecules},
      volume       = {25},
      number       = {6},
      issn         = {1420-3049},
      address      = {Basel},
      publisher    = {MDPI},
      reportid     = {FZJ-2020-01628},
      pages        = {1471},
      year         = {2020},
      abstract     = {The number of positron-emission tomography (PET) tracers
                      used to evaluate patients with brain tumors has increased
                      substantially over the last years. For the management of
                      patients with brain tumors, the most important indications
                      are the delineation of tumor extent (e.g., for planning of
                      resection or radiotherapy), the assessment of treatment
                      response to systemic treatment options such as alkylating
                      chemotherapy, and the differentiation of treatment-related
                      changes (e.g., pseudoprogression or radiation necrosis) from
                      tumor progression. Furthermore, newer PET imaging approaches
                      aim to address the need for noninvasive assessment of
                      tumoral immune cell infiltration and response to
                      immunotherapies (e.g., T-cell imaging). This review
                      summarizes the clinical value of the landscape of tracers
                      that have been used in recent years for the above-mentioned
                      indications and also provides an overview of promising newer
                      tracers for this group of patients},
      cin          = {INM-3 / INM-4},
      ddc          = {540},
      cid          = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406},
      pnm          = {572 - (Dys-)function and Plasticity (POF3-572)},
      pid          = {G:(DE-HGF)POF3-572},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:32213992},
      UT           = {WOS:000530248700214},
      doi          = {10.3390/molecules25061471},
      url          = {https://juser.fz-juelich.de/record/874716},
}